Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Fluicell. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Fluicell's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Fluicell has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Fluicell's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Fluicell's earnings growth to the Sweden market average as no estimate data is available.
Unable to compare Fluicell's revenue growth to the Sweden market average as no estimate data is available.
Unable to determine if Fluicell is high growth as no earnings estimate data is available.
Unable to determine if Fluicell is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Fluicell's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Ms. Victoire Viannay has been Chief Executive Officer at Fluicell AB (publ) since 2017. Previously, Ms. Viannay served as the Chief Operating Officer of Fluicell AB. Former Legal & HR Assistant Manager at Institut Curie, former Project Leader at Chalmers University of Technology, former Chief HR and Legal Officer at PSL Research University, she has more than 10 years of experience in labor laws, human resources and legal management, particularly in the field of scientific research. She holds a PhD in Law from Université Paris II Panthéon/Assas.
Insufficient data for Victoire to compare compensation growth.
Insufficient data for Victoire to establish whether their remuneration is reasonable compared to companies of similar size in Sweden.
Management Team Tenure
Average tenure and age of the
management team in years:
The tenure for the Fluicell management team is about average.
Chief Executive Officer
Chief Financial Officer
Gavin D. Jeffries
CTO & Director
Chief Scientific Officer
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the Fluicell board of directors is about average.
What Type Of Shareholder Owns Fluicell AB (publ)'s (STO:FLUI)?
A look at the shareholders of Fluicell AB (publ) (STO:FLUI) can tell us which group is most powerful. … Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … With a market capitalization of kr67m, Fluicell is a small cap stock, so it might not be well known by many institutional investors.
Breaking Down Fluicell AB (publ)'s (STO:FLUI) Ownership Structure
Today, I will be analyzing Fluicell AB (publ)’s (STO:FLUI) recent ownership structure, an important but not-so-popular subject among individual investors. … The implications of these institutions’ actions can either benefit or hinder individual investors, so it is important to understand the ownership composition of your stock investment. … Therefore, it is beneficial for us to examine FLUI's ownership structure in more detail.
Who Are Fluicell AB (publ)'s (STO:FLUI) Major Shareholders?
Check out our latest analysis for Fluicell OM:FLUI Ownership_summary May 22nd 18 Insider Ownership I find insiders are another important group of stakeholders, who are directly involved in making key decisions related to the use of capital. … Private Company Ownership Potential investors in FLUI should also look at another important group of investors: private companies, with a stake of 14.88%, who are primarily invested because of strategic and capital gain interests. … An ownership of this size indicates a strong financial backing and has the potential to influence FLUI's business strategy.
Fluicell AB (publ) (STO:FLUI): Does The Earnings Decline Make It An Underperformer?
Understanding how Fluicell AB (publ) (OM:FLUI) is performing as a company requires looking at more than just a years' earnings. … Today I will run you through a basic sense check to gain perspective on how Fluicell is doing by comparing its latest earnings with its long-term trend as well as the performance of its medical equipment industry peers. … I prefer to use the ‘latest twelve-month’ data, which either annualizes the most recent 6-month earnings update, or in some cases, the most recent annual report is already the latest available financial data.
Fluicell AB (publ) provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company offers BioPen PRIME and BioPen FLEX microfluidic systems for maintaining localized solution delivery in single-cell experiments, as well as enabling control of the chemical environment around single intact cells in tissue or cell cultures; and Dynaflow Resolve system, a secondary ion channel screening platform, which allows for recording of various ion channel current in patch-clamp recording configuration. The company was founded in 2012 and is based in Gothenburg, Sweden.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.